Welcome to our blog for Intellectual Property Law and Practice in Latin America!
¡Bienvenidos a nuestro blog de Derecho y Práctica de la Propiedad Intelectual en Latinoamérica!
Bem-vindo ao nosso blog sobre Direito e Prática de Propriedade Intelectual na América Latina!

Wednesday, 4 November 2009

Patricia Covarrubia

Premio Planeta 2002 prize winner found liable

    No comments:
Alfredo Bryce Echenique, known as the winner of the ‘Premio Planeta 2002’ for his novel “ the garden of my beloved” has been sentenced by the INDECOPI.

The decision comes after the writer allegedly copied 16 articles from different media (nationally and internationally). In January 2009,the first administrative instance at the Copyright Commission – INDECOPI held that Mr Bryce has infringed moral rights which are protected under ‘Ley sobre el derecho de autor’;specifically, the right of integrity (Art 25) and the paternity right (Art 24). The writer was fined 71,000 new soles ($56,000 approx).

Mr Bryce appealed to the decision on the grounds that there were improprieties in the proceeding such as: the defendant (Mr Bryce) was not properly notified in his legal domicile which was in Barcelona, Spain; that the alleged copied articles were published in Spain and therefore, the Peruvian courts lacked of jurisdiction; and lastly, that the first administrative instance did not take into consideration the principles of proportionality and reasonableness. Moreover, there was, according to him, a pending request for defence to the institution as to declare invalid the resolution.

The National Institute for the Defence of Competition and Intellectual Property Protection (INDECOPI in Spanish) upheld, through the Intellectual Property Chamber, the first instance decision. It confirmed that there were not improprieties in the process and that the Peruvian law grants right to authors irrespective of nationality or place of publication (Art 203). What is more, it also extended the decision to mention that the fine was proportional to the infringements since they were repeated (Art 186 (f)) and disseminated through mass media (Art 186 (e)).

I believe indeed that the penalty imposed is proportional to the harm caused. However, how is this fine going to be distributed? Usually compensation for the alleged infringement is made to the editorials – the copyright owner. However, as we are in presence of moral rights, should not compensation be to the authors? The law does not explain this point, Art 186 and Art 194 only set up how compensation must be established.

After hearing the sentence the writer said that he will resort to the judiciary, believing that the judicial system is more reliable that the administrative one. There is under Peruvian law the possibility of a civil and penal proceedings . However, I do not expect a u-turn if the case goes into trial. The key issues are the ‘amount taken’ and the ‘use made’ of the work. As the case stands, it appears to be against Mr Bryce because there have been substantial copy and the use was for commercial purposes (Art 186 (b)). He could also be in front of a penal action and thus, could put himself in jail for no less than 2 years (Art 217).
Read More

Tuesday, 3 November 2009

Patricia Covarrubia

Facebook is looking to target the Latin American market

    No comments:

The biggest social network, which has more than 300 million users, has expressed its intention for closer relations in the Latin American market. Michael Murphy, worldwide sales vicepresidente at Facebook, explained that Facebook is a great place for brands. At the moment, there is a large portion of ‘Latinos’ visiting the website; from these, one million are developing applications for the site. He believes that Facebook is a great place for consumers who would like to share and create business opportunities.


Facebook’s advertisers want closer relations with users and they are planning to do so through Fox Point. Hector Costa, senior vice president and general manager of Fox Point Networks for Latin America, said that “in Latin America web advertising penetration is growing at double digits every year. Advertisers want to use social networks to advertise their goods and services”.


Murphy, also explains that Facebook has a link to advertisers in different formats and so a brand can send messages to users. Nevertheless, he said that this is just a business model which is in test phase. All the same, he confirms that Facebook’s revenue comes from advertising. As for competition, he mentions that Facebook differs from others like Twitter and MySpace in that people on Facebook register with their real name, and other networks of people are anonymous, "so Facebook is a safer space for brands to reach out to consumers."


Facebook is working as any other media - professionally. They are not taking advantage of the cyber space – are you listening...metatags, keywords, hyperlink and finally adwords? We can note a straightforward business agreement. There is ‘consent’ to display an advertisement. That said, if we do not discuss here the issue of whether an average consumer will be confused or not by these new way of advertisements, it is clear that there are ‘fair practices’ in which the cyber world can integrate marketing and advertising without raising concerns to trade mark owners.

Read More

Monday, 2 November 2009

Patricia Covarrubia

Backgrounder about Ecuador's compulsory license

    No comments:

Essential Action is an organisation which is involved in a variety of projects, mainly encouraging citizens to become more connected in their communities. At the moment, the organisation is working in Ecuador providing technical and legal assistance to the Ecuadorean government in the issue of compulsory licenses (a hot topic in our blog).

Peter Maybarduk, attorney for Essential Action, has made available online the backgrounder for us all to read. He has kindly offered any further assistance in the area (you can contact him via e-mail at peter.maybarduk@essentialinformation.org).

Many thanks Peter and keep the good work!

You can read the backgrounder here.

Read More
Gilberto Macias (@gmaciasb)

OK al uso de caracteres no latinos en las direcciones de Internet

El ICANN, organismo que se encarga de gestionar lo relacionado con los dominios en Internet, acaba de aprobar el uso de cualquier alfabeto en la creación de direcciones de Internet.

Tras una reunión que tuvo lugar en Seúl, la ICANN emitió un comunicado en el que aventuraba un aumento significativo en el número de usuarios de Internet gracias a esta medida, ya que desde ahora miles y miles de personas podrán escribir las direcciones web en sus lenguas maternas, la red gana en accesibilidad para millones de personas (más de la mitad de los 1.600 millones de internautas de la actualidad se manejan en idiomas con alfabetos no latinos).

Hasta ahora, sólo podían usarse 37 caracteres: 26 letras del alfabeto latino, 10 dígitos y un guión. A partir del próximo año, los nombres de dominio podrán ser ser los caracteres de cualquier idioma. Algunos ya adelantan algunos problemas que podría acarrear esta iniciativa.

"Esto es sólo el primer paso, pero es uno muy grande y un paso histórico hacia la internacionalización de Internet", aseguraba Rod Beckstrom, presidente de la ICANN, en la nota. "Acabamos de hacer de Internet algo mucho más accesible para millones de personas en regiones como Asia, Oriente Medio y Rusia".

La primera fase del programa empezará el próximo 16 de noviembre aunque sólo se permitirá usar caracteres no latinos en nombres de dominio de nivel superior, por ejmplo, los chinos solamente podrán usar caracteres chinos en direcciones web que terminen en “.cn”.
Read More
Jeremy

Rio 2016: IOC, Brazil have preliminary parley

Sify News reports that the International Olympic Committee and the Brazilian authorities have held a two-day meeting in order to draw up a formal action plan for the 2016 Olympic Games. Brazil was represented by Sports Minister Orlando Silva, Rio de Janeiro's Governor Sergio Cabral and Mayor Eduardo Paes, as well as the head of the Rio 2016 host committee Carlos Arthur Nuzman.

Elsewhere, in USA Today, Governor Cabral is reported as saying that Rio will put up to 40,000 extra police on the streets during the Games. While this move is seen as a precaution against drug-related and security incidents, it may also indirectly dampen enthusiasm for speculative ambush marketing efforts.
Read More

Sunday, 1 November 2009

Jeremy

BPTO v ANVISA: pharmaceutical patents in Brazil

In what has become a classical issue in recent years, the battle between the examination of pharmaceutical patent applications by the Brazilian Patent and Trademark Office (BPTO) and the Health National Surveillance Agency, also known as ANVISA, we may probably have reached its highpoint.

This time, a new player is in the game: the Federal General Attorney and his recently-issued Opinion no 210, after a formal request brought by the BPTO.

The issue is this: what is the role of ANVISA, on the examination of patent applications related with pharmaceutical products and processes? Does it extend to the examination of patentability requirements or is it limited to dealing with public health matters?

At the centre of the discussion is the current draft of article 229º C of the Brazilian Intellectual Property Law that states:
“The granting of patents to pharmaceutical products and processes depends upon the prior approval of the Health National Surveillance Agency.”
Under this provision, ANVISA examines pharmaceutical patent applications and, if they meet the patentability requirements (novelty, inventive step and industrial application), as the BPTO currently does, this creates a double examination on the same invention.

The current legal framework has already led the BPTO and ANVISA to issue contradictory decisions, but the final wording belongs to ANVISA, to the despair of patent applicants. This also gave ANVISA the power to substantially interfere on IP policy matters, through an aggressive and effective policy regarding the protection and development of the generics industry, the promotion of the issuance of more compulsory licenses, and the support of Bills against the patentability of second medical use, leaving the BPTO in a less visible position.

Surprisingly, the issued Opinion goes completely in the opposite way, against ANVISA’s interests. The Federal General Attorney understands that ANVISA has indeed the power to examine pharmaceutical patent applications, but only under a public health perspective. Thus the patentability requirements of a pharmaceutical invention can only be examined by the BPTO.

This Opinion also focuses on the issue of the patents granted by the BPTO under the pipeline system and that were not previously forward to ANVISA’s examination. In this case, the Federal General Attorney recommends that ANVISA should be given the opportunity to examine these patents on a public health approach.

The Federal General Attorney submitted this Opinion to Presidential approval. For now, let us wait to see what will be the President’s decision on this matter and the respective consequences for both Agencies.

By Jorge Miguel Arruda da Veiga (Di Blasi, Parente, Vaz e Dias & Asociados); posted by Jeremy
Read More

Friday, 30 October 2009

Patricia Covarrubia

The right to a hearing – more news from Ecuador and the ‘compulsory licenses’ Decree

    No comments:

Surely the first part of the title does not sound quite IP related. However, following Ecuador news in the issue of ‘compulsory licenses’, it was the only principle of law that cross my mind. Yesterday, the Pharmaceutical Industry Research (IFI in Spanish) has accepted the Government’s decision to regulate pharmaceutical patents, considering it to be democratic. However, it its statement there were two issues that are relatively attention-grabbing.


Firstly, IFI agrees that patents prevent the production of cheap medicines but needless to say, it emphasises that patents are the means to achieve balance between innovation and public interest. Point that I agree with.


Secondly, IFI regrets for not having been invited to participate in the process. I completely disagree with this action. Isn’t it a general rule that persons whose interest are visible affected by a decision taken by a public authority must be given the opportunity to formulate their own views? I believe that this right must be respected even if the relevant proceedings were merely administrative proceedings. This procedure clearly affects the Pharmaceutical Industry. Specifically, those 177 transnational companies which control 82% of the medicines industry in the country.


It is my understanding that the Decree is in line with the Ecuadorian Constitution and international agreements, and that it incorporates requirements of the WTO’s TRIPS Agreement and the Andean Community legislation. However, is it just this tango dancer who is moving alone and seeing a violation of a well developed principle of law?


Nevertheless, we need to wait for clarification about the process. Will the Instituto Ecuatoriano de la Propiedad Intelectual (IEPI) notify the request to the owner of the patent concerned? Article 5 of the Decree establishes so. However, will the Institute invite the owner of the patent to submit any observations on the said request? In the same vein, as the EPI makes the first instance decision, shall a civil court have the right to review whether the procedure was correctly followed?


I believe that the arguments of the patentee shall be taken notice of. The reason is that, in one hand, it will be helpful in deciding the terms and conditions for granting such a licence and on the other hand, it will be helpful in avoiding the abuse of the provision.

Read More

Thursday, 29 October 2009

Patricia Covarrubia

'Made in Mexico'

    No comments:

Industries that prepare, manufacture and/or produce products in the region may apply to use the logo ‘made in Mexico’ (see press release in Spanish here)

The move comes, according to the Ministry of Economy, to be more recognised by consumers. This appears to be a wakeup call for the population, since it seems that consumers prefer international marks rather than national ones.

Manufacturers can download the application online (but need to be submitted in person). Once submitted in the respective office (Secretaria de Economia (SE)) a receipt will be given. An answer is expected in no more than 5 working days; if no reply is heard, authorisation is automatic!

The process appears to be straightforward. There is no much burden for the industries apart from the fact that they have to acknowledge the description of the product in question. At this stage, there is the need to indicate in which way the Mexican parts (raw material or process) are used in the making of the product (Art 8 I (d)).

This is clearly a good move from the Mexican industries; however how it this logo seen by the IP advisors? Is this a PGI but without the fuss? Or is this a collective mark? One thing I am sure of is that it is not a certification mark. There are not technical or quality standards required. May I emphasise that the only requirement is that there must be one issue that need to be ‘Mexican’.

Read More

Wednesday, 28 October 2009

Patricia Covarrubia

Forthcoming IP Forum in Mexico City

    No comments:

If you happen to be in Mexico City between 18 and 19 of November do not miss this approaching meeting. The title seems to involve IP finance and surely sounds attractive:

‘LA PROPIEDAD INDUSTRIAL COMO ELEMENTO DE COMPETITIVIDAD. LA VISIÓN DE LAS EMPRESAS IBEROAMERICANAS’ (Industrial Property as a competitive element. The vision of the Ibero-American industries).

The conference is organised by the WIPO, together with the Oficina Española de Patentes y Marcas (OEPM) and Instituto Mexicano de la Propiedad Intelectual (IMPI). This conference seeks to discuss, according to the program , the key of having and securing IP rights for the international success of your company.

For more information click here or to register, email ddri@impi.gob.mx

Read More

Tuesday, 27 October 2009

Gilberto Macias (@gmaciasb)

Brasil demandará a la Unión Europea por medicamentos genéricos.

Brasil, junto con la India, prepara un contencioso contra la Unión Europea (UE) en la Organización Mundial de Comercio (OMC), que tiene como telón de fondo el desarrollo de la producción de medicamentos genéricos en los países en desarrollo.Brasilia acusa a los europeos de frenar sistemáticamente genéricos en tránsito para países en desarrollo, violando el derecho, por las reglas de la OMC, que toda nación tiene que importar esos medicamentos, que son más baratos y están libres de patentes.

La acción europea es vista como desestabilizadora cuando se considera que varios medicamentos que son producidos por grandes laboratorios, generando US$ 30 mil millones en ventas anuales, van a perder sus patentes en los próximos años. "Un número importante de patentes va a caer en dominio público y es evidente que habrá más producción de genéricos", afirmó el embajador brasileño en la OMC, Roberto Azevedo. "Esas incertidumbres en el tránsito de genéricos por Europa son prejudiciales y violan obligaciones previstas en el Acuerdo de Trips (patentes)."

Los europeos defienden el derecho de controlar medicamentos que pasan por su territorio para combatir eventual comercio de medicamentos falsificados e insisten en que no violaron los acuerdos de la OMC.

Más información aquí, aquí y aquí
Read More